Future perspectives in melanoma research. Meeting report from the "Melanoma Research: a bridge Naples-USA. Naples, December 6 th -7 th 2010"-Reference-Cited by-同舟云学术

Future perspectives in melanoma research. Meeting report from the "Melanoma Research: a bridge Naples-USA. Naples, December 6 th -7 th 2010"

Published:2011-03-26 Issue:1 Volume:9 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Ascierto Paolo A,De Maio Eleonora,Bertuzzi Stefano,Palmieri Giuseppe,Halaban Ruth,Hendrix Mary,Kashani-sabet Mohamed,Ferrone Soldano,Wang Ena,Cochran Alistair,Rivoltini Licia,Lee Peter P,Fox Bernard A,Kirkwood John M,Ullmann Claudio Dansky,Lehmann Frederic F,Sznol Mario,Schwartzentruber Douglas J,Maio Michele,Flaherty Keith,Galon Jerome,Ribas Antoni,Yang James,Stroncek David F,Mozzillo Nicola,Marincola Franco M

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/1479-5876-9-32.pdf

Reference28 articles.

1. Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbé C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ: Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010, 363: 711-23. 10.1056/NEJMoa1003466.

2. Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, O'Dwyer PJ, Lee RJ, Grippo JF, Nolop K, Chapman PB: Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med. 2010, 363: 809-19. 10.1056/NEJMoa1002011.

3. Lane J, Bertuzzi S: Measuring the Results of Science Investments. Science. 2011, 331: 678-80. 10.1126/science.1201865.

4. Haqq C, Nosrati M, Sudilovsky D, Crothers J, Khodabakhsh D, Pulliam BL, Federman S, Allen RE, Singer MI, Leong SPL, Ljung B-M, Sagebiel RW, Kashani-Sabet M: The gene expression signatures of melanoma progression. Proc Natl Acad Sci USA. 2005, 102: 6092-7. 10.1073/pnas.0501564102.

5. Kashani-Sabet M, Rangel J, Torabian S, Nosrati M, Simko J, Jablons DM, Moore DH, Haqq C, Miller JR, Sagebiel RW: A multi-marker assay to distinguish benign nevi from malignant melanomas. Proc Natl Acad Sci USA. 2009, 106: 6268-72. 10.1073/pnas.0901185106.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System® (RTS®) gene switch as gene therapy for the treatment of glioma;Cancer Gene Therapy;2018-05-14

2. Stamping out RAF and MEK1/2 to inhibit the ERK1/2 pathway: an emerging threat to anticancer therapy;Oncogene;2015-09-14

3. Toward the Identification of Genetic Determinants of Responsiveness to Cancer Immunotherapy;Cancer Drug Discovery and Development;2015

4. Tetracycline-Regulated Mouse Models of Cancer;Cold Spring Harbor Protocols;2014-10

5. Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours;The Journal of Pathology;2013-12-10